Drug Information
Drug General Information | Top | |||
---|---|---|---|---|
Drug ID |
D0RQ0B
|
|||
Drug Name |
US9187437, 24
|
|||
Synonyms |
SCHEMBL876114; CHEMBL3909228; BDBM192144; US9187437, 24
Click to Show/Hide
|
|||
Drug Type |
Small molecular drug
|
|||
Structure |
Download2D MOL |
|||
Formula |
C26H26Cl2N4O
|
|||
Canonical SMILES |
C1CCC(CC1)(CCC2=NC(=NO2)C3=CC=CC(=C3)CN4C=NC(=C4Cl)Cl)C5=CC=CC=C5
|
|||
InChI |
1S/C26H26Cl2N4O/c27-23-24(28)32(18-29-23)17-19-8-7-9-20(16-19)25-30-22(33-31-25)12-15-26(13-5-2-6-14-26)21-10-3-1-4-11-21/h1,3-4,7-11,16,18H,2,5-6,12-15,17H2
|
|||
InChIKey |
TVHRMMKSOSXQRC-UHFFFAOYSA-N
|
|||
PubChem Compound ID |
Target and Pathway | Top | |||
---|---|---|---|---|
Target(s) | Sphingosine-1-phosphate receptor 3 (S1PR3) | Target Info | Inhibitor | [1] |
Target's Patent Info | Sphingosine-1-phosphate receptor 3 (S1PR3) | Target's Patent Info | [1] | |
KEGG Pathway | Sphingolipid signaling pathway | |||
Neuroactive ligand-receptor interaction | ||||
Pathway Interaction Database | S1P3 pathway | |||
Sphingosine 1-phosphate (S1P) pathway | ||||
Reactome | G alpha (i) signalling events | |||
Lysosphingolipid and LPA receptors | ||||
WikiPathways | Signal Transduction of S1P Receptor | |||
Small Ligand GPCRs | ||||
GPCR ligand binding | ||||
GPCR downstream signaling |
References | Top | |||
---|---|---|---|---|
REF 1 | Substituted oxadiazole compounds. US9187437. |
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.